Discovery of a Biomarker Signature That Reveals a Molecular Mechanism Underlying Diabetic Kidney Disease via Organ Cross Talk

Diabetes Care. 2022 Jun 2;45(6):e102-e104. doi: 10.2337/dc22-0145.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Letter

MeSH terms

  • Biomarkers
  • Diabetes Mellitus*
  • Diabetic Nephropathies*
  • Humans

Substances

  • Biomarkers

Associated data

  • ClinicalTrials.gov/NCT04839796